Cadila Healthcare seeks nod to raise upto Rs 10,000 crore

14 Apr 2015 Evaluate

Cadila Healthcare is seeking shareholders’ nod for raising upto Rs 10,000 crore from the capital markets by issuing equity shares, including instruments such as convertible bonds/debentures through qualified institutional placement, to capitalise on the organic and inorganic growth opportunities available in the pharma sector.

While no specific instrument of securities were identified, the board might opt for an ‘appropriate instrument in the best interests of the company’. The resolution seeks approval of shareholders to offer equity shares in one or more tranches to investors, inter alia through QIP by way of private placement.

Cadila Healthcare operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals.

Zydus Lifesciences Share Price

913.35 -1.30 (-0.14%)
01-Jan-2026 14:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.85
Dr. Reddys Lab 1250.30
Cipla 1499.60
Zydus Lifesciences 913.35
Lupin 2101.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×